Regeneron Pharmaceuticals, Inc.

Generali Investments, Management Co LLC REGN

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/9/2026

Shares

2,042

Value ($000)

1,578

Weight

0.4%

2025 Q3 - 2026 Q1 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/9/2026	1,578	0.4%	2,042	3/31/2026
2025 Q4	1/29/2026	1,440	0.3%	1,866	12/31/2025
2025 Q3	11/12/2025	676	0.1%	1,202	9/30/2025